Latest Market Entry News

Bio-Gene Technology Limited updates on its development of two novel insecticides, Flavocide and Qcide, highlighting regulatory progress, commercial partnerships, and a strong market outlook across multiple sectors.

Bio-Gene Technology reports significant progress in developing its bio-insecticides Flavocide and Qcide, including new efficacy data and organic certification, positioning the company for growth amid rising global demand for safer pest control.

Biotron Limited has launched a $1.5 million non-renounceable rights issue to fund its strategic acquisition of Sedarex Limited and support ongoing drug development programs. The capital raise follows shareholder approval and aims to diversify Biotron’s portfolio with a next-generation general anaesthetic.

Clover Corporation delivered a robust FY25 with strong second-half sales and operational milestones, positioning itself for continued growth in FY26 amid ongoing innovation and market expansion.

SRJ Technologies has partnered with CAPSA Engineering in a $23.8 million joint venture to deliver critical electrical asset integrity services for a Middle Eastern National Oil Company, marking a major step in its regional expansion.

Airtasker Limited has announced a $10 million equity capital raise to accelerate marketing efforts in the UK and US, following a strong first quarter with group revenue up 20.5% year-on-year. Strategic partnerships, including a cornerstone investment from iHeartMedia, underpin its international growth ambitions.

Argent BioPharma has locked in an A$11 million convertible financing facility to finalize its strategic acquisition of AusCann assets and accelerate its growth plans, including a potential US stock exchange listing.

Anteris Technologies has gained FDA approval to start patient recruitment in the US for its pivotal PARADIGM Trial, following initial European regulatory success. The company advances manufacturing and clinical readiness as it pushes toward key regulatory milestones.

Megaport Limited has announced a fully underwritten A$200 million equity raising to fund its acquisition of Latitude.sh, a global Compute-as-a-Service platform, alongside a strategic investment to accelerate network expansion in India. The acquisition is expected to significantly enhance Megaport’s revenue and EBITDA on a pro forma basis for FY25.

Tungsten Mining has secured a listing on the US OTCQB exchange and launched a Denver office, marking a strategic push into North America’s critical minerals market.

Cleo Diagnostics has identified a significantly larger U.S. patient population for its pre-surgical ovarian cancer test, expanding its commercial opportunity ahead of next year’s market entry.

Metal Powder Works has secured a strategic partnership with Hardchrome Engineering, expecting USD 1-2 million in sales over the next year from innovative bronze alloy powders for laser cladding applications.